Cell Signaling Technology Webinar to Discuss Antibody Validation, Reproducibility and the Need for Change

Share Article

The webinar will discuss the role vendors, researchers, and journals should play in minimizing irreproducibility, October 27, 2016.

Anthony Couvillon, PhD; Scientific Marketing Project Manager at Cell Signaling Technology.

Antibodies are an indispensable tool in scientific research, however, these reagents are often faulted for their lack of reproducibility. This disconnect is due in part to the availability of antibodies from hundreds of vendors and resellers whose definitions of validation and consistency vary significantly.

According to Cell Signaling Technology (CST), a shared solution may be at hand. While antibody suppliers should be responsible for their products, vendors alone cannot resolve the reproducibility “crisis.” Since a key part of the process is how antibodies are validated and used in the laboratory, researchers can play a crucial role by more carefully following established protocols, and tapping the expertise of scientists who developed and tested the antibodies they use in their experiments. Journals too, should rigorously enforce policies regarding materials and methods, or develop unambiguous means to identify and describe the use of biological reagents in the research they publish, CST says.

CST is sponsoring a new, free educational webinar, “Achieving Reproducibility: Don’t Let Antibodies be a Variable in Your Experiment,” during which the speaker will discuss the role vendors, researchers, and journals should play in minimizing irreproducibility. CST’s antibody validation process will be outlined, and the speaker will offer researchers tips for selecting and using antibodies in their research. Continuing education credits will be offered through the PACE system.

The speaker is Anthony Couvillon, PhD, Scientific Marketing Project Manager at Cell Signaling Technology. During his tenure at CST, he has developed and validated over 100 antibody products, and has considerable experience in the proteomics space. Prior to joining CST, Couvillon earned his Ph.D. in Molecular Physiology and Biophysics at Vanderbilt University and served as a postdoctoral fellow at the Harvard Medical School. He has spent much of his career using and developing affinity-based methods and assays. Currently, Couvillon is responsible for coordinating CST’s antibody reproducibility efforts, working with both internal and external scientists to ensure that CST meets or exceeds the industry standards for antibody validation.

The free webinar, hosted by LabRoots, will be presented on October 27, 2016, at 9 a.m. PT, 12 p.m. ET. For full details about the event, continuing education credits, and free registration, click here.

About Cell Signaling Technology:
Cell Signaling Technology is a private, family-owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. The company’s employees operate worldwide from its US headquarters in Massachusetts, and offices in the Netherlands, China, and Japan.

About LabRoots:
LabRoots is the leading scientific social networking website and producer of educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Karen Sorenson
LabRoots, Inc.
+1 (619) 861-0590
Email >
Visit website